NeoGenomics
266 hedge funds and large institutions have $2.11B invested in NeoGenomics in 2026 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 95 increasing their positions, 62 reducing their positions, and 42 closing their positions.
16,712% more call options, than puts
Call options by funds: $135M | Put options by funds: $801K
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
112% more capital invested
Capital invested by funds: $995M → $2.11B (+$1.12B)
53% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 62
43% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 42
8% more ownership
Funds ownership: 103.35% → 111.35% (+8%)
5% more funds holding
Funds holding: 253 → 266 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$38.1M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$24.6M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$23.1M |
| 4 |
NAMI
Nomura Asset Management International
Philadelphia,
Pennsylvania
|
+$15.3M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$11.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$19M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.2M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$6.75M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.96M |
| 5 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
-$5.07M |
NEO Hedge Fund Activity: Q2 2026 in Review
266 of the 8,300 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2026, worth a combined $2.11B — up 112% from $995M a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new NEO positions and 42 closed out — a net gain of 18 holders — while 95 added to existing stakes and 62 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $38.1M. The largest seller was D.E. Shaw & Co, cutting an estimated $19M.
- 266 institutional investors held NeoGenomics (NEO) as of Q2 2026, up from 253 in Q1 2026.
- Funds reported $2.11B of NeoGenomics stock for Q2 2026, up 112% quarter-over-quarter.
- 60 funds opened new NeoGenomics positions in Q2 2026 and 42 closed out, a net change of +18 holders.
- The largest NeoGenomics buyer in Q2 2026 was First Trust Advisors, an estimated $38.1M added.
- The largest NeoGenomics seller in Q2 2026 was D.E. Shaw & Co, an estimated $19M sold.
Based on aggregated 13F filings for Q2 2026.